医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
19期
234-234
,共1页
C反应蛋白%白介素6%麝香保心丸%血清炎症%冠脉病变
C反應蛋白%白介素6%麝香保心汍%血清炎癥%冠脈病變
C반응단백%백개소6%사향보심환%혈청염증%관맥병변
C reactive protein%Interleukin 6%Shexiang Baoxin Pil%Serum inflammation%Coronary artery disease
研究显示血清炎症反应标志物悦反应蛋白(悦砸孕)、白介素6(陨蕴-6)的水平与冠状动脉粥样硬化有关[1]。悦砸孕、陨蕴-6水平增高是造成急性冠脉综合症(ACS)患者病情恶化的主要原因之一,能够反映冠脉病变的严重程度。本文旨在观察ACS患者应用麝香保心丸治疗前后血清炎症反应标志物悦砸孕、陨蕴-6水平的变化,以进一步探讨麝香保心丸在冠心病治疗中的作用。
研究顯示血清炎癥反應標誌物悅反應蛋白(悅砸孕)、白介素6(隕蘊-6)的水平與冠狀動脈粥樣硬化有關[1]。悅砸孕、隕蘊-6水平增高是造成急性冠脈綜閤癥(ACS)患者病情噁化的主要原因之一,能夠反映冠脈病變的嚴重程度。本文旨在觀察ACS患者應用麝香保心汍治療前後血清炎癥反應標誌物悅砸孕、隕蘊-6水平的變化,以進一步探討麝香保心汍在冠心病治療中的作用。
연구현시혈청염증반응표지물열반응단백(열잡잉)、백개소6(운온-6)적수평여관상동맥죽양경화유관[1]。열잡잉、운온-6수평증고시조성급성관맥종합증(ACS)환자병정악화적주요원인지일,능구반영관맥병변적엄중정도。본문지재관찰ACS환자응용사향보심환치료전후혈청염증반응표지물열잡잉、운온-6수평적변화,이진일보탐토사향보심환재관심병치료중적작용。
To study the serum inflammatory markers of C reactive protein (CRP), interleukin 6 (IL-6)levels and coronary atherosclerosis [1]. CRP, the increased level of IL-6 is the cause of acute coronary syndrome (ACS) is one of the main causes of deterioration in patients with severe, can reflect the degree of coronary artery disease. This paper is to investigate the ef ects of ACStreated with Shexiang Baoxin Pil changes of seruminflammatory markers CRP, IL-6 before and after treatment,in order to further explore the musk ef ect of Baoxin Pil in the treatment of coronary heart disease.